Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male p… https://t.co/3CvXwZ62WS